CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
1.020
+0.030 (3.02%)
At close: Jan 30, 2026, 4:00 PM EST
0.9601
-0.0600 (-5.87%)
After-hours: Jan 30, 2026, 4:15 PM EST
CASI Pharmaceuticals Market Cap
CASI Pharmaceuticals has a market cap or net worth of $20.96 million as of January 30, 2026. Its market cap has decreased by -46.63% in one year.
Market Cap
20.96M
Enterprise Value
35.13M
1-Year Change
-46.63%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since June 12, 1996, CASI Pharmaceuticals's market cap has decreased from $101.76M to $20.96M, a decrease of -79.40%. That is a compound annual growth rate of -5.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 20.96M | 20.00% |
| Dec 31, 2025 | 17.47M | -60.16% |
| Dec 31, 2024 | 43.84M | -54.03% |
| Dec 29, 2023 | 95.38M | 291.63% |
| Dec 30, 2022 | 24.35M | -78.22% |
| Dec 31, 2021 | 111.84M | -69.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 23.28M |
| ProMIS Neurosciences | 22.95M |
| Klotho Neurosciences | 22.80M |
| Traws Pharma | 22.53M |
| Neuphoria Therapeutics | 21.78M |
| Allarity Therapeutics | 20.84M |
| BioAtla | 20.64M |
| IN8bio | 20.22M |